Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for painless bronchoscopy with EBUS-TBNA
ChiCTR2000040637Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in pulmonary diseases comparing Propofol group with Remimazolam group (2 arms). Primary endpoint: Hypoxic incidence. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
pulmonary diseases
Beyond the preview
Go deeper on ChiCTR2000040637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040637.